Resistance training trial in patients with cancer-related wasting
Patients with pancreatic or lung cancer and wasting had less deterioration in body composition with supervised training than usual care. Substantial dropout limits confidence in this small trial.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
In patients with pancreatic or lung cancer and cancer-related wasting, usual care was associated with worse body composition than supervised resistance training at the final assessment. The trial also examined participation and adverse events. Substantial dropout and missing details about the body composition difference make the result preliminary rather than a firm effectiveness conclusion.
Dropout was 45.5%, and the abstract gives no size or detailed measure for the body composition difference. Improvements within a group do not by themselves establish superiority over usual care.
What researchers found
Between-group body composition result
At 24 weeks, usual care versus supervised training; p = 0.026. The specific measure and difference size were not reported.
Participation and reported safety
Exercise adherence was 63.7%. Clinical adverse events were similar between groups; 2 events during or after exercise resolved fully. These findings describe participation and reported safety in this trial but do not establish safety for all patients.
Other improvements need context
Earlier assessments showed improvements within the training group in physical performance and patient-reported outcomes. Usual care participants also improved in reported depression and activity. These separate within-group changes should not be interpreted as proof of a treatment advantage.
The original publication
Resistance training in cachectic pancreatic and lung cancer patients: randomised controlled trial.
Niels T, Stich L, Siebert S et al.
BMJ Support Palliat Care · 2025
- PubMed ID
- 40628493
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.